They act like a hormonal "carpet bomb," affecting your entire body—not just your muscles. The purpose of SARMs is to investigate their potential for muscle hypertrophy, skeletal health, and bone integrity in preclinical models. It is used to fill the gap of low testosterone levels (hypogonadism) in preclinical models. In the case of regulatory status, testosterone is the best option, since it is FDA-approved. Regarding the legal status of these compounds, SARMs have not been approved by the FDA for human use. The low testosterone levels also affect sexual health and libido (low sexual drive). In this article, you’ll learn what SARMs are, how they work, the most common side effects, and why they’re more risky than they first appear. They are not for human or animal consumption, medical use, or any use not permitted by applicable law. By entering this website, you acknowledge that all products sold by Behemothlabz are intended strictly for research purposes only. These products are not intended for human dosing, injection, or ingestion. Take SARMs for example, from the doctor’s perspective, those are potentially unsafe, unregulated and under researched compounds. The problem with both SARMs and testosterone, especially the former, is that doctors are very unlikely to prescribe them to you. I’ve seen plenty of articles online claiming SARMs are the "new testosterone" but that is a bunch of bull. Right now, it’s actually safer to imbue testosterone in a controlled environment as it has more research behind it. The primary goal is to restore normal testosterone levels. Along with hypogonadism, medical experts may use testosterone treatments for metastatic breast cancer or delayed puberty. There have been multiple FDA-approved products for male sexual dysfunction, hypogonadism, and more. N this video, we're going to discuss RAD140, Testolone, SARMs, TRT, and testosterone with a medical provider. That is, taking SARMs doesn’t guarantee you’ll transform your body—it still requires dedication. You also won’t see the full stack of compounds and doses used—or the post-cycle therapy required to recover—so it’s hard to know what someone risked to get those results. You won’t see suppressed testosterone, abnormal bloodwork, or any of the other hobgoblins that come with SARMs use. If the results were disappointing—or came with visible side effects—you’d never see them. When you stop the SARM, your testosterone doesn’t bounce back immediately. Not to the degree that oral steroids do, but measurably. The marketing premise—"androgens without the downsides"—is scientifically unfounded. Most SARMs achieve maybe 60-80% of testosterone’s activation intensity. Non-selective agonists such as testosterone are able to recruit coactivators when bound to AR but not corepressors and hence are agonists in all tissues. Like other type I nuclear receptors, the unliganded androgen receptor (AR) resides in the cytosol complexed with heat shock proteins (HSP). SARMs are not substrates of 5α-reductase, hence they are not selectively activated like testosterone in tissues such as prostate. The net result is that testosterone and its metabolite together are not tissue selective.
